The Allstate Co. (NYSE:ALL – Free Report) – Research analysts at Zacks Research lowered their Q2 2025 earnings per share estimates for shares of Allstate in a research report issued to clients and investors on Monday, March 10th. Zacks Research analyst Z. Masood now expects that the insurance provider will post earnings per share of $3.04 for the quarter, down from their prior estimate of $3.08. The consensus estimate for Allstate’s current full-year earnings is $18.74 per share. Zacks Research also issued estimates for Allstate’s Q3 2025 earnings at $4.21 EPS, Q4 2025 earnings at $6.40 EPS, FY2025 earnings at $17.65 EPS, Q1 2026 earnings at $5.16 EPS, Q2 2026 earnings at $3.94 EPS, Q4 2026 earnings at $7.28 EPS and FY2026 earnings at $20.98 EPS.
ALL has been the subject of a number of other reports. Piper Sandler increased their target price on Allstate from $206.00 to $244.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 26th. Keefe, Bruyette & Woods increased their target price on Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 11th. Argus raised Allstate from a “hold” rating to a “buy” rating in a research note on Monday, March 3rd. Evercore ISI raised Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Finally, The Goldman Sachs Group increased their target price on Allstate from $209.00 to $230.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $217.94.
Allstate Stock Performance
Shares of ALL stock opened at $202.00 on Thursday. The company has a market cap of $53.54 billion, a price-to-earnings ratio of 11.89, a price-to-earnings-growth ratio of 1.01 and a beta of 0.47. The stock has a 50 day simple moving average of $191.39 and a 200-day simple moving average of $192.21. Allstate has a 12-month low of $156.66 and a 12-month high of $209.88. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42.
Allstate (NYSE:ALL – Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, topping analysts’ consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%.
Institutional Investors Weigh In On Allstate
Several hedge funds have recently made changes to their positions in ALL. VSM Wealth Advisory LLC acquired a new stake in shares of Allstate during the fourth quarter worth $25,000. FSA Wealth Management LLC acquired a new stake in shares of Allstate during the third quarter worth $26,000. Twin Tree Management LP acquired a new stake in shares of Allstate during the fourth quarter worth $27,000. Vision Financial Markets LLC acquired a new position in Allstate in the fourth quarter valued at $29,000. Finally, Hopwood Financial Services Inc. acquired a new position in Allstate in the fourth quarter valued at $29,000. Institutional investors and hedge funds own 76.47% of the company’s stock.
Insider Buying and Selling at Allstate
In other news, CFO Jesse E. Merten sold 40,102 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the sale, the chief financial officer now owns 18,115 shares in the company, valued at $3,378,990.95. This trade represents a 68.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.80% of the stock is owned by insiders.
Allstate declared that its Board of Directors has authorized a share buyback plan on Wednesday, February 26th that permits the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization permits the insurance provider to reacquire up to 3% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.
Allstate Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th will be issued a dividend of $1.00 per share. This represents a $4.00 dividend on an annualized basis and a yield of 1.98%. The ex-dividend date of this dividend is Monday, March 10th. This is a boost from Allstate’s previous quarterly dividend of $0.92. Allstate’s dividend payout ratio is 23.54%.
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
See Also
- Five stocks we like better than Allstate
- Options Trading – Understanding Strike Price
- 3 Undervalued Stocks You Can Buy at a Discount Now
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- How to Invest in Blue Chip Stocks
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.